Concepedia

Publication | Open Access

Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial

DOIFull Paper Access

92

Citations

20

References

2019

Year

Margaret Johnson, Princy Kumar, Jean‐Michel Molina, Giuliano Rizzardini, Pedro Cahn, Markus Bickel, Josep Mallolas, Yan Zhou, Cristiana Morais, Sushma Kumar,
JAIDS Journal of Acquired Immune Deficiency Syndromes

Abstract

ClinicalTrials.gov NCT02397096.

References

YearCitations

Page 1